Dr Tadataka Yamada has been a Director of CSL Limited since September 2016.Skills and experience:
Dr Yamada has broad and extensive experience with global corporate and not-for profit organisations in the pharmaceutical and medical sector. He has a deep understanding of medical technologies, research and development and provides strategic global insight to understanding the health access issues and the changing external environment.
Prior to this, he was the Chief Medical and Scientific Officer at Takeda Pharmaceuticals, as well as a Member of the Board. He has also held the role of President on the Bill & Melinda Gates Foundation Global Health Program and prior to that was Chairman of Research and Development at GlaxoSmithKline. Dr Yamada has received an honorary appointment as Knight Commander of the Most Excellent Order of the British Empire.Other directorships and offices (current and recent):
- Director of Agilent Technologies Inc. (since March 2011)
- Chairman of Clinton Health Access Initiative (since March 2017)
- Venture Partner at Frazier Healthcare (since June 2015)
- Member of the Innovation and Development Committee